Glipatab 10 mg Tablet is an antidiabetic medication classified as a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It is primarily used to manage blood glucose levels in adults with type 2 diabetes mellitus, particularly when diet and exercise alone are insufficient. Additionally, Glipatab has been shown to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.